Company Monitoring Page for Roche

latest headlines for company on cafepharma

Beyond Flatiron: The Rising Power Of Oncology Clinical Data Companies
Forbes
Fri, 03/9/18 - 10:52 am
Tags:
oncology, Clinical Data, Flatiron Health, Roche
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Endpoints
Thu, 03/8/18 - 09:39 am
Tags:
clinical trials, VBL Therapeutics, VB-111, Roche, Avastin, glioblastoma
Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
Endpoints
Thu, 03/1/18 - 11:48 pm
Tags:
Roche, Ionis Pharmaceuticals, clinical trials, Huntington's disease, IONIS-HTT Rx
Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance
RAPS.org
Tue, 02/27/18 - 10:40 pm
Tags:
Pfizer, Roche, Allergan, FDA, patients, drug development
In wake of Tecentriq bladder cancer bust and lost market share, Roche tries Tesaro combo
Fierce Pharma
Tue, 02/27/18 - 06:45 pm
Tags:
Roche, Tecentriq, bladder cancer, Zejula, PARP inhibitors
Shionogi, Roche get their first approval for the next big thing in fighting the flu
Endpoints
Fri, 02/23/18 - 09:28 am
Tags:
Shionogi, Roche, Flu, influenza, Xofluza, Japan, Tamiflu
The Deeply Human Core of Roche's $2.1B Tech Acquisition - And Why They Did It
Forbes
Sun, 02/18/18 - 02:54 pm
Tags:
Roche, M&A, oncology, R&D, Flatiron Health, EHRs
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
Tags:
AbbVie, Allergan, Roche, Biogen, UCB Pharma, Acorda Therapeutics, M&A
Roche to Acquire Cancer Software Startup Flatiron Health for $1.9B
Xconomy
Thu, 02/15/18 - 11:40 pm
Tags:
Roche, software, Flatiron Health, M&A
Roche posts positive PhII results for bispecific antibody eye drug, joining Novartis in rivalry with Eylea
Endpoints
Mon, 02/12/18 - 09:49 am
Tags:
Roche, bispecific antibodies, RG7716, Novartis, Eylea
Array melanoma drugs show significant survival versus Roche drug in study
Reuters
Wed, 02/7/18 - 09:58 am
Tags:
Array Biopharma, melanoma, Roche, encorafenib, binimetinib
Roche hails another PhIII win on Tecentriq combo, reports promising kidney cancer data
Endpoints
Mon, 02/5/18 - 07:07 pm
Tags:
Roche, Tecentriq, kidney cancer
Biopharma in charts: Key takeaways from Q4 earnings
Biopharma Dive
Mon, 02/5/18 - 12:35 pm
Tags:
earnings, Merck, JNJ, AbbVie, Roche, Celgene, Eli Lilly
Roche announces slower growth in 2018 and investors lose interest in it
GoinPharma
Thu, 02/1/18 - 09:46 pm
Tags:
Roche, earnings
Roche silently scraps two one-time blockbuster hopefuls as $725M Seragon deal craters
Endpoints
Thu, 02/1/18 - 09:49 am
Tags:
Roche, Seragon, M&A, RG-6047
Roche scores an unusual ‘breakthrough’ at the FDA for an autism drug
Endpoints
Mon, 01/29/18 - 09:22 am
Tags:
Roche, FDA, breakthrough status, autism, RG7314, balovaptan
Pfizer’s latest copycat could put the squeeze on Roche — again
Endpoints
Fri, 01/26/18 - 10:57 am
Tags:
Pfizer, Roche, biosimilars, Rituxan, PF-05280586
Roche doesn’t give up, plans recovery for Diabetes Care unit
GoinPharma
Sun, 01/21/18 - 09:03 pm
Tags:
Roche, diabetes
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Fierce Pharma
Tue, 01/16/18 - 06:56 pm
Tags:
Roche, Pharma CEOs, Severin Schwan, biosimilars, Herceptin, Rituxan, Avastin
Roche granted approval for ocrelizumab (multiple sclerosis) in Europe
GoinPharma
Sat, 01/13/18 - 10:48 pm
Tags:
Roche, ocrelizumab, Europe, MS, multiple sclerosis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.